Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association

By P. Wilson, Y. Woo, Johnston, A. Khera, D. Lloyd‐Jones, Sue A. Nelson, G. Nichol, Diane, Dracup, M. Ezekowitz and 7 more. Circulation, 2011

2,972 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/974f79c35881516a4c777bf401a0f7b119be5421

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. I. Graham
2. J. Despres
3. Alan S. Go
4. Amin Ul Haq
5. Jose Luis Zamorano
6. Emelia J. Benjamin
7. D. Mozaffarian

In Public Health, Environmental and Occupational Health

1. I. Graham
2. Simin Liu
3. J. Despres
4. D. Mozaffarian
5. F. B. Hu

Citations in the corpus

• Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. (2012, background): “CARDIOVASCULAR DISEASE (CVD) is the leading cause of deaths in the United States ( 800 000, or about 1 in 3 overall deaths/y),(1) with estimated annual direct and overall costs of $273 billion and $444 billion, respectively.(2) Previous epidemiologic studies indicate that individuals who meet an inc”
• 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (2016, background): “Targeting lower levels in the health impact pyramid will also address the socio-economic divide in CV health, which has not diminished despite major improvements in the treatment of CVD in recent decades.(9,10)”